Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Charter Communications
CHTR
5
MasterCard
MA
US OptionsDetailed Quotes
GH250516P25000
- 0.05
- 0.000.00%
15min DelayClose May 6 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume28 Open Interest25.00Strike Price0.00Turnover152.49%IV40.50%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0128Delta0.0032Gamma838.60Leverage Ratio-0.0163Theta-0.0001Rho-10.76Eff Leverage0.0022Vega
Guardant Health Newsroom
Piper Sandler Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $60
Piper Sandler Maintains Overweight on Guardant Health, Raises Price Target to $60
Scotiabank Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $57
Guardant Health Is Maintained at Sector Outperform by Scotiabank
Guardant Health Analyst Ratings
Scotiabank Keeps Their Buy Rating on Guardant Health (GH)
Leerink Partners Maintains Guardant Health(GH.US) With Buy Rating, Announces Target Price $65
J.P. Morgan Maintains Guardant Health(GH.US) With Buy Rating, Raises Target Price to $60
A Quick Look at Today's Ratings for Guardant Health(GH.US), With a Forecast Between $50 to $70
Morgan Stanley Raises Price Target on Guardant Health to $60 From $52, Keeps Overweight Rating
Analysts Offer Insights on Healthcare Companies: Guardant Health (GH), Humana (HUM) and Evolus (EOLS)
Stifel Maintains Buy on Guardant Health, Raises Price Target to $60
Barclays Maintains Overweight on Guardant Health, Raises Price Target to $60
Guardant Health Is Maintained at Buy by TD Securities
Guardant Health Price Target Raised to $60.00/Share From $56.00 by TD Securities
Guardant Health Analyst Ratings
UBS Maintains Buy on Guardant Health, Raises Price Target to $70
Guardant Health: Strong Financial Performance and Strategic Positioning Drive Buy Rating
CCORF Maintains Guardant Health(GH.US) With Buy Rating
Guardant Health's Strategic Advancements in Multi-Cancer Detection Reinforce Buy Rating
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call